Close X


closed call

Call: Clinical research for the validation of biomarkers and/or diagnostic medical devices

Logo
Programme
Horizon 2020
Acronym H2020
Type of Fund Action programme
Description of programme
"Horizon 2020"
Horizon 2020 is the biggest EU Research and Innovation programme with nearly 80 billion € of funding available over 7 years (2014 to 2020). Apart from classic research projects, Horizon 2020 also funds innovation projects and pilot-projects in different fields.
The programme is divided into three different sections:
  1. Excellent Science
  2. Industrial Leadership
  3. Societal Challenges
Countries eligible for funding are: The EU-Member States, Iceland, Norway, Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro, Serbia, Turkey, Moldova, Switzerland, Ukraine, Faroe Islands, Israel, Tunisia, Georgia, Armenia.
Link http://ec.europa.eu/programmes/horizon2020/
Description of programme
"Health, Demographic Change and Wellbeing"

Responding to the challenge of an aging population, research and innovation (R&I) under Horizon 2020 is an investment in better health for all. It aims to keep older people active and independent for longer and supports the development of new, safer and more effective interventions. R&I under Horizon 2020 also contributes to the sustainability of health and care systems.

Title Horizon 2020 Dedicated SME Instrument Phase 1 and 2, 2014-2015
Description of call
"Horizon 2020 Dedicated SME Instrument Phase 1 and 2, 2014-2015"

Leadership in enabling and industrial technologies (LEIT) includes the parts of Horizon 2020 focusing on new opportunities for industrial leadership in Key Enabling Technologies (KETs), ICT and space. These are areas of key industrial competences determining Europe’s global competitiveness. Aiming at new and breakthrough technologies, this part of the programme will contribute to boosting competitiveness, creating jobs and supporting growth. It will help to achieve the EU Industrial policy1 goals and represents an important component of the EU Strategy for Key Enabling Technologies.

Select Origin of Applicant EU Member States


Albania / Shqipëria
Bosnia and Herzegovina
Former Yugoslav Republic of Macedonia / поранешна југословенска Република Македонија
Iceland / Ísland
Moldova
Montenegro / Crna Gora/Црна Гора
Norway / Norge
Serbia / Сpбија
Switzerland / Schweiz / Suisse / Svizzera
Turkey / Türkiye
Ukraine / Україна Oukraïna
Others
Call
Clinical research for the validation of biomarkers and/or diagnostic medical devices
Description of call
"Clinical research for the validation of biomarkers and/or diagnostic medical devices"

Biomarkers are used in clinical practice to describe both normal and pathological conditions. They can also have a prognostic or a predictive power. They are therefore increasingly used in medicine and many potential biomarkers are proposed every year.

Only a few of them are however validated for use in a clinical research setting. Such validation implies the demonstration of a link to a pertinent clinical endpoint or process, as well as a robust and appropriate analytical method.

The clinical validation of biomarkers will be increasingly important for the development of new diagnostics, and this is a research area where many small European companies are active.

Improved clinical decisions should lead to better health outcomes while contributing to the sustainability of the health care system.

Thematic Focus Biotechnology, Research, Health, Innovation, SME, Technologies
Funding area EU Member States
Candidate Countries
Iceland / Ísland
Moldova
Norway / Norge
Switzerland / Schweiz / Suisse / Svizzera
Others
Select Origin of Applicant EU Member States


Albania / Shqipëria
Bosnia and Herzegovina
Former Yugoslav Republic of Macedonia / поранешна југословенска Република Македонија
Iceland / Ísland
Moldova
Montenegro / Crna Gora/Црна Гора
Norway / Norge
Serbia / Сpбија
Switzerland / Schweiz / Suisse / Svizzera
Turkey / Türkiye
Ukraine / Україна Oukraïna
Others
Eligible applicants Education and Training Centres, Research Institution, Small and Medium Sized Enterprises, SMEs (between 10 and 249 employees), NGO / NPO, Start Up Company, University, Enterprise (more than 250 employees or not defined), Association
Project Partner Yes
Recurring Call No
Contact Details

Link to the National Contact Point Finder.


Register now and benefit from additional services - it is free of cost!

News

Published on 25.09.2018

Interreg Alpine Space

Interreg Alpine Space

Link to Call

Published on 19.09.2018

Local and regional integration networks

AMIF - Asylum, Migration and Integration Fund

Link to Call
Loading Animation